Freedom Capital Markets Maintains Buy on Nutex Health, Raises Price Target to $306

Benzinga · 1d ago
Freedom Capital Markets analyst Gene Mannheimer maintains Nutex Health (NASDAQ:NUTX) with a Buy and raises the price target from $280 to $306.